Group 1 - The company Tian Shi Li announced on September 17 that it will hold the 14th meeting of the 9th Board of Directors on September 17, 2025, to approve the proposal to use idle funds to purchase bank wealth management products, with a maximum investment of 3 billion RMB [1] - The funds can be used on a rolling basis within the approved limit, and the transaction amount at any point during the investment period, including reinvested earnings, shall not exceed 3 billion RMB [1] - As of the report date, the market capitalization of Tian Shi Li is 23.8 billion RMB [1] Group 2 - For the fiscal year 2024, the revenue composition of Tian Shi Li is as follows: Traditional Chinese medicine accounts for 70.89%, chemical preparations 15.38%, pharmaceutical commerce 10.53%, biological drugs 2.25%, and chemical raw materials 0.61% [1]
天士力:拟使用额度不超过30亿元投资银行理财产品